Alison D Grant Selected Research

Clofazimine (Lamprene)

1/2020

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison D Grant Research Topics

Disease

53	Tuberculosis (Tuberculoses) 07/2023 - 09/2003
10	Infections 07/2023 - 06/2002
8	HIV Infections (HIV Infection) 10/2021 - 06/2002
5	Anemia 07/2022 - 01/2008
3	Silicosis 01/2022 - 06/2005
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2021 - 01/2020
3	Malaria 07/2010 - 01/2004
2	Latent Tuberculosis 01/2021 - 01/2014
2	Viremia 01/2011 - 12/2009
2	Hepatitis B 12/2008 - 06/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2008 - 06/2002
1	Hypertension (High Blood Pressure) 08/2021
1	Sudden Death 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2021
1	Noncommunicable Diseases 01/2021
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Ataxia (Dyssynergia) 01/2020
1	Chronic Disease (Chronic Diseases) 05/2015
1	Reinfection 04/2014
1	Latent Infection 04/2014
1	Pulmonary Tuberculosis 04/2012
1	Silicotuberculosis 05/2011
1	Coinfection 12/2008
1	Chronic Hepatitis B 12/2008
1	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2008
1	Vomiting 01/2008
1	Dizziness (Lightheadedness) 01/2008
1	Neutropenia 01/2008
1	Nausea 01/2008
1	Exanthema (Rash) 01/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2008

Drug/Important Bio-Agent (IBA)

21	Isoniazid (Ftivazide)FDA LinkGeneric 10/2021 - 06/2005
20	GoldIBA 07/2023 - 09/2003
5	lipoarabinomannan (LAM)IBA 07/2022 - 01/2015
4	Tuberculin (PPD)IBA 07/2023 - 11/2003
4	Hemoglobins (Hemoglobin)IBA 07/2022 - 02/2008
3	bedaquiline (R207910)IBA 08/2021 - 01/2020
2	AntigensIBA 07/2023 - 01/2015
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2021
2	VaccinesIBA 12/2017 - 06/2002
2	RNA (Ribonucleic Acid)IBA 11/2011 - 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	rifapentine (Priftin)FDA Link 10/2021
1	AzolesIBA 08/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021
1	InterferonsIBA 01/2021
1	Clofazimine (Lamprene)FDA Link 01/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2012
1	Indicators and Reagents (Reagents)IBA 04/2012
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2010
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2010
1	Reverse Transcriptase InhibitorsIBA 12/2009
1	NucleosidesIBA 12/2009
1	Oxygen (Dioxygen)IBA 02/2008
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2007
1	insulin receptor-related receptor (IRR)IBA 06/2005
1	Mefloquine (Lariam)FDA LinkGeneric 01/2004
1	Chloroquine (Aralen)FDA LinkGeneric 01/2004
1	Proguanil (Paludrine)FDA Link 01/2004
1	Antimalarials (Antimalarial Agents)IBA 01/2004
1	AIDS VaccinesIBA 06/2002

Therapy/Procedure

35	Therapeutics 10/2021 - 09/2003
9	Art Therapy 01/2020 - 12/2008
4	Highly Active Antiretroviral Therapy (HAART) 05/2015 - 01/2008
1	Personal Protective Equipment 03/2022
1	Inappropriate Prescribing 01/2021
1	Treatment Delay 04/2015
1	Insecticide-Treated Bednets 12/2004